SEC Form 4 · accession 0000914760-16-000387
ENZO BIOCHEM INC · ENZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Michael O'Brien
Officer — SVP of Finance
Period of report
Mar 14, 2016
Accepted (ET)
Mar 16, 2016 · 4:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000316253
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (to acquire common stock)F1 | $4.35 | Mar 14, 2016 | A | 26,000 | A | Mar 15, 2017 | Mar 13, 2021 | Common Stock | 26,000 | 61,000 | D |
Explanation of responses
- F1The Reporting Person was granted 26,000 stock options. The options have a five-year term and shall vest in three equal annual tranches, begininning March 15, 2017.